Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibody lateral flow assay for antibody prevalence studies following vaccination: a diagnostic accuracy study. (2021)
Attributed to:
MRC Centre for Global Infectious Disease Analysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.12688/wellcomeopenres.17231.2
PubMed Identifier: 35673545
Publication URI: http://europepmc.org/abstract/MED/35673545
Type: Journal Article/Review
Volume: 6
Parent Publication: Wellcome open research
ISSN: 2398-502X